Idenix Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference

Idenix Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare
Conference

CAMBRIDGE, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals,
Inc. (Nasdaq:IDIX) announced today that Idenix management will present a
corporate overview at the 31^st Annual J.P. Morgan Healthcare Conference on
January 9, 2013 at 2:00 p.m. PT at the Westin St. Francis in San Francisco. 

The live and archived webcast of the company presentation can be accessed
under "Events and Presentations" in the Idenix Investor Center at
www.idenix.com. Please log in approximately 5-10 minutes before the event to
ensure a timely connection. The archived replay will be available on the
Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development of drugs
for the treatment of human viral diseases. Idenix's current focus is on the
treatment of patients with chronic hepatitis C infection. For further
information about Idenix, please refer to http://www.idenix.com.

CONTACT: Idenix Pharmaceuticals Contacts:
         Kelly Barry (617) 995-9033 (media)
         Teri Dahlman (617) 995-9807 (investors)
 
Press spacebar to pause and continue. Press esc to stop.